Terazosin Hydrochloride is a selective alpha-1 adrenoceptor antagonist belonging to the quinazoline class of pharmaceuticals, widely indicated for the treatment of hypertension and symptomatic benign prostatic… Read more
Terazosin Hydrochloride is a selective alpha-1 adrenoceptor antagonist belonging to the quinazoline class of pharmaceuticals, widely indicated for the treatment of hypertension and symptomatic benign prostatic hyperplasia. This compound functions by relaxing smooth muscle tissue in the bladder neck and prostate to improve urinary flow while simultaneously dilating blood vessels to reduce blood pressure. Analytical laboratories rely on high-quality reference standards for Terazosin Hydrochloride to perform precise impurity profiling and method validation during pharmaceutical development and manufacturing. This category provides access to essential materials for quality control testing, including pharmacopeial and non-pharmacopeial impurities, degradation products, and stable isotope-labelled compounds. These research materials are critical for ensuring the accuracy of quantitative analysis, identifying potential metabolic pathways, and maintaining compliance with regulatory standards throughout the lifecycle of the drug product.